Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways

SIMPLE SUMMARY: Osteosarcoma (OS), which accounts for about 35% of bone malignancy, shows aggressive progression in adults, adolescents, and children. Neoadjuvant chemotherapy provides an improvement in survival for OS patients; however, a molecular level understanding of the disease mechanisms is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Southekal, Siddesh, Shakyawar, Sushil Kumar, Bajpai, Prachi, Elkholy, Amr, Manne, Upender, Mishra, Nitish Kumar, Guda, Chittibabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093233/
https://www.ncbi.nlm.nih.gov/pubmed/37046795
http://dx.doi.org/10.3390/cancers15072134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093233/
https://www.ncbi.nlm.nih.gov/pubmed/37046795
http://dx.doi.org/10.3390/cancers15072134

Ejemplares similares